Explore
Trendline
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Sales and Earnings
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Sales and Earnings
Read More
Trendline
Agilent Technologies to Release Q2 Fiscal Year 2026 Financial Results on May 27
Agilent Technologies to Release Q2 Fiscal Year 2026 Financial Results on May 27
Read More
Trendline
CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance
CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance
Read More
Trendline
Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance
Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance
Read More
Trendline
Ecopetrol to Release Q1 2026 Earnings Report and Host Conference Call
Ecopetrol to Release Q1 2026 Earnings Report and Host Conference Call
Read More
Trendline
Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges
Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges
Read More
Trendline
Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance
Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance
Read More
Trendline
Bristow Group Schedules First Quarter 2026 Earnings Call to Discuss Financial Performance
Bristow Group Schedules First Quarter 2026 Earnings Call to Discuss Financial Performance
Read More
Trendline
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings
Read More
Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
Read More
Trendline
Ituran Location and Control Ltd. Announces First Quarter 2026 Results Release and Conference Call
Ituran Location and Control Ltd. Announces First Quarter 2026 Results Release and Conference Call
Read More
Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Read More